DOCU.NASDAQDocusign, INC

Form 4: DocuSign Executive Sells 14,800 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


A DocuSign executive, Robert Chatwani, sold 14,800 shares of common stock at an average price of $97.76, under a pre-arranged 10b5-1 trading plan.

Summary

  • Robert Chatwani, President and General Manager of Growth at DocuSign, sold 14,800 shares of DocuSign common stock on December 18, 2024.
  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
  • The shares were sold at prices ranging from $97.51 to $98.10, with an average price of $97.76.
  • Following the transaction, Mr. Chatwani beneficially owns 73,414 shares of DocuSign stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an executive stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

Executive stock sales are a common occurrence and are often part of pre-planned trading strategies. This transaction is not unusual and is in line with standard practices for executives at publicly traded companies.

Comparison to Industry Standards

  • Executive stock sales are a common practice across the tech industry, with many executives using 10b5-1 plans to manage their personal finances and avoid accusations of insider trading.
  • Comparable companies such as Adobe, Salesforce, and Microsoft also see regular Form 4 filings from their executives.
  • The volume of shares sold and the price range are within typical parameters for such transactions.

Stakeholder Impact

  • The stock sale may have a minor impact on the stock price, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

DateDescription
12/18/2024Date of the stock sale transaction.

Keywords

DocuSign, insider trading, stock sale, Form 4, Robert Chatwani, Rule 10b5-1, executive transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.